AJ

Ankur Jain

Active Director Director DIN 10434784
DIN 10434784 First appointment Dec 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2023
Shareholding value Locked Premium profile

About Ankur Jain

Ankur Jain has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Mette Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10434784
Primary Designation Director
First Appointment 21 Dec 2023
Oldest Company Age 2 yrs

Current companies

Company Designation Appointment Founded Status
Director 21 Dec 2023 2023 Under Process Of Striking Off

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mette Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ankur Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankur Jain

Ankur Jain has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Mette Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ankur Jain is associated with 1 company as Director.

Ankur Jain has expertise in General Business.

Ankur Jain has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available